Publications by authors named "David B Doman"

Claim this Profile
U
Uncovering the Hidden Link Between the Aberrant Intestinal Microbiome and Fibromyalgia.
Ade Waterman, Stavros A Doumas, Michele Fischer, Mark Mattar, Samer Charbel, David B Doman

Gastroenterol Hepatol (N Y)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression and the Aberrant Intestinal Microbiome.
Ann F Kopera, Yii Chun Khiew, Mohd Amer Alsamman, Mark C Mattar, Raena S Olsen, David B Doman

Gastroenterol Hepatol (N Y)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Emerging Therapeutic Options for Gastroparesis.
Aung S Myint, Brandon Rieders, Mohammed Tashkandi, Marie L Borum, Joyce M Koh, David B Doman

Gastroenterol Hepatol (N Y)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of Current Concepts in Gastric Intestinal Metaplasia and Gastric Cancer.
David S Jencks, Jason D Adam, Marie L Borum, Joyce M Koh, Sindu Stephen, David B Doman

Gastroenterol Hepatol (N Y)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders.
Brian P Ciampa, Emmanuel Reyes Ramos, Marie Borum, David B Doman

Gastroenterol Hepatol (N Y)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep Dysfunction and Gastrointestinal Diseases.
Vikesh Khanijow, Pia Prakash, Helene A Emsellem, Marie L Borum, David B Doman

Gastroenterol Hepatol (N Y)· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis.
Woo Jung Lee, Lakshmi D N Lattimer, Sindu Stephen, Marie L Borum, David B Doman

Gastroenterol Hepatol (N Y)· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapeutic options for eosinophilic esophagitis.
Timothy Dougherty, Sindu Stephen, Marie L Borum, David B Doman

Gastroenterol Hepatol (N Y)· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet.
Anita Bakshi, Sindu Stephen, Marie L Borum, David B Doman

Gastroenterol Hepatol (N Y)· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future role of serogenomics in ulcerative colitis.
Mark H Flasar, Raymond K Cross, David B Doman

Gastroenterol Hepatol (N Y)· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future role of biomarkers in Crohn's disease risk assessment and treatment.
Cyrus P Tamboli, David B Doman, Amar Patel

Clin Exp Gastroenterol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cells in gastrointestinal disease.
David B Ramsay, Sindu Stephen, Marie Borum, Lysandra Voltaggio, David B Doman

Gastroenterol Hepatol (N Y)· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probiotic therapy for irritable bowel syndrome.
George Aragon, Deborah B Graham, Marie Borum, David B Doman

Gastroenterol Hepatol (N Y)· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging therapeutic role of probiotics in inflammatory bowel disease.
Matthew Chandler, Eric Wollins, Anastasia Toles, Marie Borum, David B Doman

Gastroenterol Hepatol (N Y)· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Ecologic niche" therapy for Crohn's disease with adjunctive rifaximin antibiotic treatment followed by Flora-Q probiotic maintenance therapy.
David B Doman, Howard J Goldberg, Martin I Golding

Am J Gastroenterol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Take your Pill(Cam): it might save your life.
Martin I Golding, David B Doman, Howard J Goldberg

Gastrointest Endosc· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis